Summary
Biogen Idec Inc. (BIIB) filed an 8-K on April 23, 2008, primarily to announce its financial results for the first quarter ended March 31, 2008. The report incorporates by reference a press release (Exhibit 99.1) detailing the company's performance during the period. Investors should refer to this press release for specific operational and financial metrics, as the 8-K itself does not contain the detailed financial data but rather serves as a notification of its public release. The furnishing of this press release under Item 2.02 is important to note. It means the information is provided to the SEC for public disclosure but is not considered 'filed' for certain legal purposes, such as Section 18 of the Exchange Act. This distinction is crucial for understanding the legal implications of the disclosed information.
Key Highlights
- 1Biogen Idec filed an 8-K on April 23, 2008, to report Q1 2008 financial results.
- 2The core of the filing is Exhibit 99.1, a press release announcing the company's results of operations and financial condition for the three months ended March 31, 2008.
- 3The 8-K itself does not contain detailed financial tables or commentary; investors must consult the referenced press release for this information.
- 4The press release is furnished under Item 2.02 of Form 8-K, meaning it is not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934.
- 5This filing serves as a notification of the public release of Q1 2008 financial and operational data.